Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function

Journal of Child Neurology

Volumn 25, Issue 9, 2010, Pages 1103-1109

  Sienko Thomas, Susan ^a   Buckon, Cathleen E ^a   Nicorici, Alina ^b   Bagley, Anita ^b   McDonald, Craig M ^b   Sussman, Michael D ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

Duchenne muscular dystrophy; energy; function; gait

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; ENERGY EXPENDITURE; GAIT; HUMAN; MALE; MOBILIZATION; MOTOR PERFORMANCE; MUSCLE FUNCTION; ORTHOTICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD;

ADRENAL CORTEX HORMONES; CHILD; DISABILITY EVALUATION; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 77956323075     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810371002     Document Type: Article

References (18)

1. Sussman M. Duchenne muscular dystrophy. J Am Acad Orthop Surg. 2002 ; 10: 138-151.
2. Balaban B., Matthews DJ, Clayton GH, Carry T. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil. 2005 ; 84: 843-850.
3. Biggar WD, Harris VA, Eliasoph L., Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord. 2006 ; 16: 249-255.
4. Carter GT, McDonald CM Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy. Am J Phys Med Rehabil. 2000 ; 79: 455-458.
5. Carriero A., Zavatsky A., Stebbins J., Theologis T., Shefelbine SJ Determination of gait patterns in children with spastic diplegic cerebral palsy using principal components. Gait Posture. 2009 ; 29: 71-75.
6. Mulroy S., Gronley J., Weiss W., et al. Use of cluster analysis for gait pattern classification of patients in the early and late recovery phases following stroke. Gait Posture. 2003 ; 18: 114-125.
7. Toro B., Nester C., Farren P. Cluster analysis for the extraction of sagittal gait patterns in children with cerebral palsy. Gait Posture. 2007 ; 25: 157-165.
8. Sutherland D. Myopathic disorders. In: Sutherland D, ed. Gait Disorders in Childhood and Adolescence. Baltimore, MD: Williams and Wilkins ; 1984: 152-166.
9. D'Angelo M., Berti M., Piccinini L., et al. Gait pattern in Duchenne muscular dystrophy. Gait Posture. 2009 ; 29: 36-41.
10. Ounpuu S. Patterns of gait pathology. In: Gage J, ed. The Treatment of Gait Problems in Cerebral Palsy. London: Mac Keith Press; 2004: 217-237.
11. Schwartz M., Rozumalski A. The Gait Deviation Index: a new comprehensive index of gait pathology. Gait Posture. 2008 ; 28: 351-357.
12. Bowen T., Miller F., Mackenzie W. Comparison of oxygen consumption measurements in children with cerebral palsy to children with muscular dystrophy. J Pediatr Orthop. 1999 ; 19: 133-136.
13. Russell D., Rosenbaum P., Avery L., Lane M. Gross Motor Function Measure (GMFM-66 & GMFM-88) User's Manual. London: Mac Keith Press ; 2002.
14. Rab G., Petuskey K., Bagley A. A method for determination of upper extremity kinematics. Gait Posture. 2002 ; 15: 113-119.
15. Hsu J., Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993 ; 288: 122-125.
16. Sutherland D., Olsen R., Cooper L., et al. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981 ; 23: 3-22.
17. Nelson L., Owens H., Hynan L., Iannaccone S. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscul Disord. 2006 ; 16: 374-380.
18. Drouin LM, Malouin F., Richards CL, Marcoux S. Correlation between the gross motor function measure scores and gait spatiotemporal measures in children with neurological impairments. Dev Med Child Neurol. 1996 ; 38: 1007-1019.